scispace - formally typeset
H

Hozefa S. Bandukwala

Researcher at La Jolla Institute for Allergy and Immunology

Publications -  28
Citations -  8596

Hozefa S. Bandukwala is an academic researcher from La Jolla Institute for Allergy and Immunology. The author has contributed to research in topics: DNA methylation & T cell. The author has an hindex of 19, co-authored 28 publications receiving 7711 citations. Previous affiliations of Hozefa S. Bandukwala include Harvard University & University of Chicago.

Papers
More filters
Journal ArticleDOI

Conversion of 5-Methylcytosine to 5-Hydroxymethylcytosine in Mammalian DNA by MLL Partner TET1

TL;DR: It is shown here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro.
Journal ArticleDOI

Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2

TL;DR: The results demonstrate that Tet2 is important for normal myelopoiesis, and suggest that disruption of TET2 enzymatic activity favours myeloid tumorigenesis, which may prove valuable as a diagnostic and prognostic tool to tailor therapies and assess responses to anticancer drugs.
Journal ArticleDOI

Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice

TL;DR: It is shown that Tet2 is a critical regulator of self-renewal and differentiation of hematopoietic stem cells (HSCs) and has a critical role in regulating the expansion and function of HSCs, presumably by controlling 5hmC levels at genes important for the self-Renewal, proliferation, and differentiation.
Journal ArticleDOI

Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation.

TL;DR: A regulatory module in DCs is revealed by which IRF4 modulates IL-10 and IL-33 cytokine production to specifically promote Th2 differentiation and inflammation.
Journal ArticleDOI

Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX

TL;DR: It is shown that IDAX, a reported inhibitor of Wnt signalling that has been implicated in malignant renal cell carcinoma and colonic villous adenoma, regulates TET2 protein expression, and that the expression and activity of TET3 is also regulated through its CXXC domain.